Abstract
Cyclin G1 is one of the target genes of the transcription factor p53, and is induced in a p53-dependent manner in response to DNA damage. Although cyclin G1 has been implicated in a range of biological phenomena, its precise function remains unclear. Here we present an analysis of the physiological role of cyclin G1 using mice homozygous for a targeted disruption of the cyclin G1 gene. In order to clarify the role of cyclin G1 in the p53 pathway, downstream events such as apoptosis, cell growth and cell cycle checkpoint control were analysed in thymocytes and embryonic fibroblasts derived from cyclin G1-disrupted mice. No difference was detected in induction of apoptosis between mouse embryo fibroblasts (MEFs) derived from cyclin G1+/+ and cyclin G1−/− mice. Following irradiation, cyclin G1−/− MEFs proliferated more slowly and reached lower cell densities in culture dishes than cyclin G1+/+ MEFs. Analysis of cell survival showed that cyclin G1−/− MEFs were about twice as sensitive as cyclin G1+/+ MEFs to γ radiation or UV radiation. Cyclin G1−/− mice were more sensitive to γ radiation than wild-type mice. Flow cytometeric analysis revealed that the number of cyclin G1−/− MEFs in G2/M phase after irradiation was reduced by 50% relative to cyclin G1+/+ MEFs. Our results demonstrate that cyclin G1 plays roles in G2/M arrest, damage recovery and growth promotion after cellular stress.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amundson SA, Myers TG, Fornace Jr AJ . 1998 Oncogene 17: 3287–3299
Asahina H, Han Z-B, Kawanishi M, Kato Jr T, Ayaki H, Todo T, Yagi T, Takebe H, Ikenaga M, Kimura SH . 1999 Mutation Res. 435: 255–262
Attardi LD, Lowe SW, Brugarolas J, Jack T . 1996 EMBO J. 15: 3693–3701
Barak Y, Juven T, Haffner R, Oren M . 1993 EMBO J. 12: 461–468
Bates S, Vousden KH . 1999 Cell Mol. Life Sci. 55: 28–47
Bates S, Rowan S, Vousden KH . 1996 Oncogene 13: 1103–1109
Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ . 1995 Nature 377: 552–557
Choisy Rossi C, Reisdorf P, Yonish Rouach E . 1998 Toxicol. Let. 102–103: 491–496
Dameron KM, Volpert OV, Tainsky MA, Bouck N . 1994 Science 265: 1582–1584
Deng C, Zhang P, Harper JW, Elledge SJ, Leder P . 1995 Cell 82: 675–684
Ding HF, Fisher DE . 1998 Crit. Rev. Oncog. 9: 83–98
Edwards MC, Wong C, Elledge SJ . 1998 Mol. Cell. Biol. 18: 4291–4300
El-Deiry WS . 1998 Curr. Top. Microbiol. Immunol. 227: 121–137
Fantes P, Brooks R . 1993 The Cell Cycle: A Practical Approach IRL Press: Oxford pp 6–9
Fu TJ, Peng J, Lee G, Price DH, Flores O . 1999 J. Biol. Chem. 274: 34527–34530
Giaccia AJ, Kastan MB . 1998 Genes Dev. 12: 2973–2983
Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B . 1997 Mol. Cell 1: 3–11
Horne MC, Donaldson KL, Goolsby GL, Tran D, Mulheisen M, Hell JW, Wahl AF . 1997 J. Biol. Chem. 272: 12650–12661
Horne MC, Goolsby GL, Donaldson KL, Tran D, Neubauer M, Wahl AF . 1996 J. Biol. Chem. 271: 6050–6061
Hunter T . 1991 Semin. Cell Biol. 2: 213–222
Ikawa M, Wada I, Kominami K, Watanabe D, Toshimori K, Nishimune Y, Okabe M . 1997 Nature 387: 607–611
Janus F, Albrechtsen N, Dornreiter I, Wiesmuller L, Grosse F, Deppert W . 1999 Cell Mol. Life Sci. 55: 12–27
Jayaraman L, Prives C . 1999 Cell Mol. Life Sci. 55: 76–87
Kanaoka Y, Kimura SH, Okazaki I, Ikeda M, Nojima H . 1997 FEBS Lett. 402: 73–80
Kemp CJ, Wheldon T, Balmain A . 1994 Nature Genet. 8: 66–69
Kimura SH, Kataoka TR, Endo Y, Nojima H . 1997a Geonomics 46: 483–486
Kimura SH, Tsuruga H, Yabuta N, Endo Y, Nojima H . 1997b Genomics 44: 179–187
Kong M, Barnes EA, Ollendorff V, Donoghue DJ . 2000 EMBO J. 19: 1378–1388
Levine AJ . 1997 Cell 88: 323–331
Miyashita T, Reed JC . 1995 Cell 80: 293–299
Morgenstern JP, Land H . 1990 Nucleic Acids Res. 18: 3587–3596
Morita N, Kiryu S, Kiyama H . 1996 J. Neurosci. 16: 5961–5966
Nakamura T, Sanokawa R, Saski RS, Ayusawa D, Oishi M, Mori N . 1995 Exp. Cell Res. 221: 534–542
Okamoto K, Beach D . 1994 EMBO J. 13: 4816–4822
Okamoto K, Kamibayashi C, Serrano M, Prives C, Mumby MC, Beach D . 1996 Mol. Cell. Biol. 16: 6593–6602
Okamoto K, Prives C . 1999 Oncogene 18: 4606–4615
Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 90: 8392–8396
Pines J . 1991 Cell Growth Differ. 2: 305–310
Pines J, Hunter T . 1989 Cell 58: 833–846
Reimer CL, Borras AM, Kurdistani SK, Garreau JR, Chung M, Aaronson SA, Lee SW . 1999 J. Biol. Chem. 274: 11022–11029
Robertson EJ . 1987 Teratocarcinoma and Embryonic Stem Cells, A Practical Approach IRL Press: Oxford pp 77–78
Sabbatini P, Lin J, Levine AJ, White E . 1995 Genes Dev. 9: 2184–2192
Sambrook J, Fritsch EF, Maniatis T . 1989 Molecular cloning. A Laboratory manual Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
Shimizu A, Nishida J, Ueoka Y, Kato K, Hachiya T, Kuiaki Y, Wake N . 1998 Biochem. Biophys. Res. Commun. 242: 529–533
Sionov RV, Haupt Y . 1999 Oncogene 18: 6145–6157
Skotzko M, Wu L, Anderson WF, Gordon EM, Hall FL . 1995 Cancer Res. 55: 5493–5498
Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Connor PM, Fornace Jr AJ . 1994 Science 266: 1376–1379
Smith ML. Kontny HU, Bortnick R, Fornace Jr AJ . 1997 Exp. Cell Res. 230: 61–68
Tamura K, Kanaoka Y, Jinno S, Nagata A, Ogiso Y, Shimizu K, Hayakawa T, Nojima H, Okayama H . 1993 Oncogene 8: 2113–2118
Tybulewicz VLJ, Crawford CE, Jackson PK, Bronson RT, Mulligan RC . 1991 Cell 65: 1153–1163
Wei P, Garber ME, Fang SM, Fischer WH, Jones KA . 1998 Cell 92: 451–462
Wu X, Bayle H, Olson D, Levine AJ . 1993 Genes Dev. 7: 1126–1132
Zauberman A, Lupo A, Oren M . 1995 Oncogene 10: 2361–2366
Acknowledgements
We thank Ms Kaori Yamauchi, Mr Tatsuki R Kataoka and Mr Yuichiro Koma for technical assistance and Dr Naohisa Yoshioka for the retroviral vector, pBabe-Puro. This work was supported by grants from the Ministry of Education, Science and Culture, Japan and grants from the Osaka Cancer Society, Uehara Foundation, Yasuda Medical Research Foundation, Welfide Medical Research Foundation and Osaka Cancer Research Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kimura, S., Ikawa, M., Ito, A. et al. Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery. Oncogene 20, 3290–3300 (2001). https://doi.org/10.1038/sj.onc.1204270
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204270
Keywords
This article is cited by
-
Radiation dose and gene expression analysis of wild boar 10 years after the Fukushima Daiichi Nuclear Plant accident
Scientific Reports (2022)
-
Atypical cyclins: the extended family portrait
Cellular and Molecular Life Sciences (2020)
-
Involvement of methylation of MicroRNA-122, −125b and -106b in regulation of Cyclin G1, CAT-1 and STAT3 target genes in isoniazid-induced liver injury
BMC Pharmacology and Toxicology (2018)
-
Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma
Indian Journal of Clinical Biochemistry (2018)
-
Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression
Scientific Reports (2017)